Database : MEDLINE
Search on : Lithiasis [Words]
References found : 5813 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 582 go to page                         

  1 / 5813 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 25617920
[Au] Autor:Crouzeix G; Kerlan V
[Ad] Address:Service d'endocrinologie, diabétologie et maladies métaboliques, CHU site de la Cavale-Blanche, Boulevard Tanguy-Prigent, 29609 Brest cedex, France. Electronic address: genevieve.crouzeix@chu-brest.fr.
[Ti] Title:Hyperparathyroïdie primaire: nouveaux concepts, nouvelles recommandations. [Primary hyperparathyroidism: new concepts, new recommendations].
[So] Source:Ann Endocrinol (Paris);75 Suppl 1:S21-36, 2014 Oct.
[Is] ISSN:0003-4266
[Cp] Country of publication:France
[La] Language:fre
[Ab] Abstract:Today, primary hyperparathyroidism (PHPT) is frequently diagnosed at an asymptomatic stage. New international guidelines presented at the Endocrine Society congress update the management of this disease. Normocalcemic PHPT is part of the diagnostic spectrum of PHPT, its natural history is poorly known, and monitoring is proposed once secondary HPT has been eliminated. Bone involvement, classically predominant in cortical bone, also affects trabecular bone. Osteodensitometry is poorly effective at the vertebral level and new methods (trabecular bone score [TBS], vertebral fracture assessment [VFA]) should improve the assessment of the risk of fracture. The kidney is the most frequently symptomatic organ, and an imaging workup as well as urinary tests are recommended in all patients when searching for causes of lithiasis or nephrocalcinosis. More than 10% of PHPT cases are related to a germinal mutation: these patients should be identified to optimize their management and that of their relatives. Medical treatment is reserved for patients for whom surgery is not indicated or possible: cinacalcet is effective for calcemia, the bisphosphonates are effective for bone involvement. Vitamin D deficiency can be corrected as long as calcemia and creatinuria are monitored. Surgical treatment is recommended in case of pronounced hypercalcemia, bone or renal involvement, and age less than 50 years and in patients in whom monitoring is refused or impossible. Studies have shown that asymptomatic PHPT evolves little in monitored patients.
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1501
[Js] Journal subset:IM
[St] Status:In-Process

  2 / 5813 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24998483
[Au] Autor:García-Galisteo E; Sánchez-Martínez N; Molina-Díaz P; López-Rueda B; Baena-González V
[Ad] Address:Servicio de Urología, Hospital Universitario Carlos Haya, Málaga, España. Electronic address: eggalisteo@yahoo.es....
[Ti] Title:Invasive treatment trends in urinary calculi in a third level hospital.
[So] Source:Actas Urol Esp;39(1):32-7, 2015 Jan-Feb.
[Is] ISSN:1699-7980
[Cp] Country of publication:Spain
[La] Language:eng; spa
[Ab] Abstract:OBJECTIVE: In the following study, we observe the progress of various invasive calculi treatments that have taken place in our hospital in the last 15 years. MATERIAL AND METHOD: We extracted data from our hospital database on patients who underwent extracorporeal shock wave lithotripsy (ESWL), endoscopic surgery and open surgery. We analyzed how the incidence of these treatments has evolved over the last 15 years. We also studied the number of publications in PubMed that reference invasive calculi treatments. RESULTS: From January 1998 to December 2012, a total of 10,947 patients were treated instrumentally for lithiasis, 9,695 of whom (90.4%) underwent ESWL and 1,034 of whom underwent endoscopic or open surgery (9.6%). The incidence of lithotripsy treatments reached its maximum in 2006, with a progressive reduction thereafter. The incidence of endoscopic surgery increased progressively until 2009 and then leveled off. We can see how in recent years there has been a clear increase in the number of studies that have covered endoscopic surgery, with a decreasing number covering ESWL. CONCLUSIONS: In our community, ESWL remains the most widely used invasive treatment for calculi. In recent years, there has been a reduction in the number of ESWL treatments and an increase in the number of endoscopic treatments, with open surgery showing a clearly decreasing trend.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1501
[Js] Journal subset:IM
[St] Status:In-Data-Review

  3 / 5813 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24791620
[Au] Autor:Cano-Castiñeira R; Carrasco-Valiente J; Pérula-de-Torres LA; Jiménez-García C; Olaya-Caro I; Criado-Larumbe M; Requena-Tapia MJ
[Ad] Address:Unidad de Gestión Clínica de Urología, Hospital Universitario Reina Sofía, Córdoba, España. Electronic address: rcanocastineira@gmail.com....
[Ti] Title:Prevalence of renal stones in Andalusian population: results of PreLiRenA study.
[So] Source:Actas Urol Esp;39(1):26-31, 2015 Jan-Feb.
[Is] ISSN:1699-7980
[Cp] Country of publication:Spain
[La] Language:eng; spa
[Ab] Abstract:INTRODUCTION: Urolithiasis is a disease having a high recurrence rate and associated morbidity. A not well quantified increase is being seen in recent years that could be related with various factors. The main purpose of our study has been to estimate urolithiasis prevalence and incidence in the region of Andalusia, determining which factors are associated. MATERIAL AND METHODS: We performed an observational and cross-sectional study. Using a multistage randomized procedure, we selected a sample of 2439 subjects, aging from 40 to 65 years old, who currently lived in Andalusia. Data was collected through phone interviews, questioning the chosen subjects about their kidney stones history, comorbidity and socio-demographic characteristics. We conducted a descriptive, bivariate and multivariate analysis with logistic regression. RESULTS: A total of 2439 subjects were surveyed. Subjects had mean age of 51.1±7.61 years -standard deviation; (95% confidence interval-95% CI: 50.70-51.30), 48.7% of whom were male. Prevalence of urolithiasis obtained was 16.4% (95% CI: 14.87-17.85%) and an incidence of 1.2 (95% CI: .74-1.64). Variables significantly associated with the presence of urolithiasis found in the multivariate study were: presence of a family history of kidney stones (odds ratio -OR: 1.91; 95% CI: 1.51-2.40, P<.001), hypertension (OR:1.58; 95% CI:1.24-2.02; P<.001), gout (OR:1.98; 95% CI: 1.26-3,12; P=.003) and a high BMI (OR: 1.60; 95% CI 1.19-2.17; p=.008). CONCLUSIONS: A significant increase in the prevalence and incidence of urolithiasis is observed in the environment in regards to the previously available figures. The presence of a family history of urolithiasis, hypertension, gout as well as having a high BMI could influence the observed epidemiological changes in renal lithiasis.
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Entry month:1501
[Js] Journal subset:IM
[St] Status:In-Data-Review

  4 / 5813 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 24519097
[Au] Autor:Sáez-Torres C; Rodrigo D; Grases F; García-Raja AM; Gómez C; Lumbreras J; Frontera G
[Ad] Address:University Institute of Health Sciences Research (IUNICS), University of Balearic Islands, Carretera de Valldemossa km 7.5, 07122, Palma de Mallorca, Spain, currisaez@telefonica.net.
[Ti] Title:Urinary excretion of calcium, magnesium, phosphate, citrate, oxalate, and uric acid by healthy schoolchildren using a 12-h collection protocol.
[So] Source:Pediatr Nephrol;29(7):1201-8, 2014 Jul.
[Is] ISSN:1432-198X
[Cp] Country of publication:Germany
[La] Language:eng
[Ab] Abstract:BACKGROUND: Improving knowledge about normal urine composition in children is important for early prevention of lithiasis. We describe urinary excretion values of calcium (Ca), magnesium (Mg), phosphate (P), citrate (Cit), uric acid (Ur), and oxalate (Ox) in healthy children with and without a family history of lithiasis, using a 12-h urine collection protocol. METHODS: Urine samples were obtained from 184 children (5-12 years): a spot sample collected in the afternoon, and a 12-h overnight sample. Solute/creatinine (Cr) and 12-h solute excretion was calculated. RESULTS: Urinary excretion values of the studied solutes are presented as percentile values, separately for each type of sample. Due to age-related differences in the solute/creatinine ratios, except for Ca and Cit, results are described according to the child's age. The presence of excretion values related to an increased risk of lithiasis was more common in children with a family history. CONCLUSIONS: We report data from urine samples collected by using a simplified collection protocol. The observed differences between children with and without a family history of lithiasis could justify that in population studies aimed at setting reference values, the former are excluded.
[Mh] MeSH terms primary: Lithiasis/urine
[Mh] MeSH terms secundary: Calcium/urine
Child
Child, Preschool
Citric Acid/urine
Creatinine/urine
Female
Humans
Lithiasis/genetics
Magnesium/urine
Male
Oxalates/urine
Phosphates/urine
Reference Values
Uric Acid/urine
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Oxalates); 0 (Phosphates); 268B43MJ25 (Uric Acid); 2968PHW8QP (Citric Acid); AYI8EX34EU (Creatinine); I38ZP9992A (Magnesium); SY7Q814VUP (Calcium)
[Em] Entry month:1503
[Js] Journal subset:IM
[Da] Date of entry for processing:140522
[St] Status:MEDLINE
[do] DOI:10.1007/s00467-014-2755-1

  5 / 5813 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25237732
[Au] Autor:Perugi G; Quaranta G; Belletti S; Casalini F; Mosti N; Toni C; Dell'Osso L
[Ad] Address:Department of Clinical and Experimental Medicine, Clinica Psichiatrica Università di Pisa, Via Roma, 67, Pisa 56126, Italy; Institute of Behavioural Sciences "G. De Lisio", Pisa, Italy. Electronic address: giulio.perugi@med.unipi.it....
[Ti] Title:General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases.
[So] Source:J Affect Disord;170:95-103, 2015 Jan 1.
[Is] ISSN:1573-2517
[Cp] Country of publication:Netherlands
[La] Language:eng
[Ab] Abstract:BACKGROUND: Patients with bipolar disorder (BD) suffer from greater physical morbidity and mortality than the general population. The aim of the present study is to explore the prevalence and clinical correlates of General Medical Conditions (GMC) in a large consecutive sample of patients with BD. METHOD: The study sample comprised of 347 patients who met DSM-IV-TR criteria for BD I (n=207, 59.7%), BD II or Cyclothymic Disorder (n=140, 40.3). Diagnostic information was collected by means of the Structured Clinical Interview for DSM-IV Axis I Disorders- Clinical Version (SCID-I), and information about personal and family history were collected by the Semi-Structured Interview for Mood Disorder-Revised (SIMD-R). Standardized procedure was used to assess the diagnosis of GMC, which was considered present only if a specific therapy to treat the condition was prescribed by a specialist or a general practitioner. In order to explore possible relationships between physical comorbidity and clinical features of BD, we compared patients with (MD) and without (No-MD) Metabolic Diseases (MD) and patients with (AAD) and without (No-AAD) Autoimmune-Allergic Diseases (AAD). RESULTS: The most commonly reported GMCs were: Headache, Hypercholesterolemia (>200mg/dl), Chronic Constipation, Obesity, Arterial Hypertension (BP >140/90 mmHg), Hypothyroidism, Allergic Rhino-Conjunctivitis, Irritable Bowel Syndrome, Hypertriglyceridemia (>150 mg/dl), Metabolic Syndrome, Hiatus Hernia, Dysmenorrhea, Urticaria, Atopic Dermatitis, Psoriasis, Seborrheic Dermatitis, Diabetes Mellitus, Bronchial Asthma, Cardiac Arrhythmias, Biliary Lithiasis, and COPD. In our sample, MD (n=148, 42.7%) and AAD (n=167, 48.1%) were the most common categories of GMCs. Interestingly, the lifetime prevalence of cancer and neoplastic diseases was very low: 1 patient (.3%) reported Lung Adenocarcinoma and 2 (.6%) patients Bowel Cancer. In the group comparisons, length of pharmacological treatment (OR=1.054; 95% CI=1.030-1.078), age at onset of first major episode (OR=1.043; 95% CI=1.019-1.067), length of the current episode (OR=1.025; 95% CI=1.020-1.533) and absence of lifetime comorbid substance abuse (OR=.373; 95% CI=.141-.989) were statistically associated with the presence of comorbid MD; while only AD-induced hypomania (OR=1.62; 95% CI=1.011-2.597), and cyclothymic temperament (OR=1.051; 95% CI=1.016-1.087) were statistically associated with the presence of comorbid AAD. LIMITATIONS: Possible referral and selection bias; retrospective, non-blind, cross-sectional evaluation. CONCLUSION: MD and AAD were highly represented in our sample, while cancer and neoplastic diseases were uncommon. The clinical correlates of different sub-groups of GMC suggest different interpretations. The presence of MD seems to be correlated with the progression of BD and the chronic medication exposure, while comorbid AAD seems to correlate with a specific clinical subtype of BD, characterized by mood reactivity and temperamental mood instability. If the link with autoimmune-allergic diathesis will be confirmed, it could provide an interesting new paradigm for the study of the "systemic" nature of mood disorders and a promising target for future treatment options.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1412
[Js] Journal subset:IM
[St] Status:In-Process

  6 / 5813 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 25675626
[Au] Autor:Cotton F; Wolff F; Simon I; Idrissi M; Tielemans C; Vanden Bossche M; Roumeguère T; Pozdzik A
[Ti] Title:Apport de la biologie clinique dans l'exploration étiologique et le suivi de l'urolithiase. [Contribution of clinical biology in the etiological exploration and follow-up of urolithiasis].
[So] Source:Rev Med Brux;35(4):243-9, 2014 Sep.
[Is] ISSN:0035-3639
[Cp] Country of publication:Belgium
[La] Language:fre
[Ab] Abstract:Urolithiasis is a frequent pathology with a constantly increasing prevalence in industrial countries. The relapse frequency is around 50 % with a risk of complications. The laboratory input is essential in the determination of the etiology and in the therapeutic monitoring. The morphoconstitutional analysis of the stone is the most important element. It comprises the examination of the stone with binocular loupes and the simultaneous analysis of its crystalline composition. This can be done by different techniques but infrared spectrophotometry is the most powerful. The chemical analysis should be definitely proscribed. The analysis of crystalluria includes the search, the identification and the counting of crystals in fresh morning urines. It is useful for the diagnosis and for the patient follow-up. Finally, the biochemical analyses in urine and serum, in first line or on the basis of the stone composition, are an important part of the etiological exploration and therapeutic monitoring.
[Mh] MeSH terms primary: Urinary Calculi/chemistry
Urolithiasis/etiology
[Mh] MeSH terms secundary: Clinical Chemistry Tests
Humans
Urine/chemistry
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1503
[Js] Journal subset:IM
[Da] Date of entry for processing:150213
[St] Status:MEDLINE

  7 / 5813 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 24504848
[Au] Autor:Carriel V; Aneiros-Fernández J; Ruyffelaert M; Arias-Santiago S; Riady V; Izquierdo-Martínez F; Roda O; Cornelissen M; Campos A; Alaminos M
[Ad] Address:Department of Histology (Tissue Engineering Group), University of Granada, Granada, Spain, Department of Basic Medical Sciences, Faculty of Medicine, Ghent University, Ghent, Belgium, and Pathology Unit, San Camilo Hospital, University of Valparaíso, San Felipe, Chile. vcarriel@ugr.es....
[Ti] Title:Histological and immunohistochemical study of an unusual type of gallbladder duplication.
[So] Source:Histol Histopathol;29(7):957-64, 2014 Jul.
[Is] ISSN:1699-5848
[Cp] Country of publication:Spain
[La] Language:eng
[Ab] Abstract:Gallbladder duplication is a rare congenital anomaly, with an incidence of 1 in 3,800 autopsies. The correct diagnosis and treatment of this type of entity is important in clinical practice, because it may cause some clinical and surgical problems. In this report, we present the clinical case of a 28-year-old female with abdominal pain. Ultrasound of the upper abdomen showed a distended gallbladder with the presence of a septum that could suggest a congenital anomaly of the extrahepatic biliary system. During surgery, a distended and inflamed gallbladder with a lithiasis was found. In addition, a complete septum and double cystic duct were observed. The gross and histopathological evaluation of the surgical specimen allowed us to confirm the diagnosis of a Y- shaped type gallbladder duplication according to Boyden's classification. In conclusion, in presence of an atypical imaging of the gallbladder, diagnosis of this group of congenital anomalies should be considered in order to adequately plan surgical intervention if necessary.
[Mh] MeSH terms primary: Gallbladder/abnormalities
[Mh] MeSH terms secundary: Adult
Female
Humans
Immunohistochemistry
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Entry month:1503
[Js] Journal subset:IM
[Da] Date of entry for processing:140706
[St] Status:MEDLINE

  8 / 5813 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
SciELO Brazil full text
Full text

[PMID]: 25251955
[Au] Autor:Turney B; Robertson W; Wiseman O; Amaro CR; Leitão VA; Silva IL; Amaro JL
[Ad] Address:Department of Urology, University of Oxford, Oxford; United Kingdom....
[Ti] Title:Use of the probability of stone formation (PSF) score to assess stone forming risk and treatment response in a cohort of Brazilian stone formers.
[So] Source:Int Braz J Urol;40(4):507-12, 2014 Jul-Aug.
[Is] ISSN:1677-6119
[Cp] Country of publication:Brazil
[La] Language:eng
[Ab] Abstract:INTRODUCTION: The aim was to confirm that PSF (probability of stone formation) changed appropriately following medical therapy on recurrent stone formers. MATERIALS AND METHODS: Data were collected on 26 Brazilian stone-formers. A baseline 24-hour urine collection was performed prior to treatment. Details of the medical treatment initiated for stone-disease were recorded. A PSF calculation was performed on the 24 hour urine sample using the 7 urinary parameters required: voided volume, oxalate, calcium, urate, pH, citrate and magnesium. A repeat 24-hour urine sample was performed for PSF calculation after treatment. Comparison was made between the PSF scores before and during treatment. RESULTS: At baseline, 20 of the 26 patients (77%) had a high PSF score (> 0.5). Of the 26 patients, 17 (65%) showed an overall reduction in their PSF profiles with a medical treatment regimen. Eleven patients (42%) changed from a high risk (PSF > 0.5) to a low risk (PSF < 0.5) and 6 patients reduced their risk score but did not change risk category. Six (23%) patients remained in a high risk category (> 0.5) during both assessments. CONCLUSIONS: The PSF score reduced following medical treatment in the majority of patients in this cohort.
[Mh] MeSH terms primary: Risk Assessment/methods
Urolithiasis/therapy
Urolithiasis/urine
[Mh] MeSH terms secundary: Adult
Aged
Calcium Phosphates/urine
Citrates/urine
Cohort Studies
Female
Humans
Magnesium/urine
Male
Middle Aged
Oxalates/urine
Probability
Reference Values
Reproducibility of Results
Risk Factors
Time Factors
Treatment Outcome
Uric Acid/urine
Urolithiasis/etiology
Urolithiasis/pathology
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Calcium Phosphates); 0 (Citrates); 0 (Oxalates); 268B43MJ25 (Uric Acid); 97Z1WI3NDX (calcium phosphate); I38ZP9992A (Magnesium)
[Em] Entry month:1502
[Js] Journal subset:IM
[Da] Date of entry for processing:140925
[St] Status:MEDLINE
[do] DOI:10.1590/S1677-5538.IBJU.2014.04.09

  9 / 5813 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25652872
[Au] Autor:Arrabal-Martin M; Poyatos-Andujar A; Del Carmen Cano-García M; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
[Ad] Address:UGC Urologia, Hospital Universitario San Cecilio, IBS Granada, Granada, Spain.
[Ti] Title:The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
[So] Source:Int Urol Nephrol;47(3):445-9, 2015 Mar.
[Is] ISSN:1573-2584
[Cp] Country of publication:Netherlands
[La] Language:eng
[Ab] Abstract:PURPOSE: Recurrent kidney stones are associated with bone mineral density loss, altered bone remodeling markers, hypercalciuria and increased in fasting calcium/creatinine ratio. The objective was to determine biochemical alterations in urine in patients with osteopenia/osteoporosis without calcium kidney stones compared with patients with calcium kidney stones. METHODS: This is a cross-sectional study including 142 patients who were divided in two groups: Group 1 (patients with recurrent calcium kidney stones) and Group 2 (patients with osteopenia/osteoporosis in the lumbar spine or hip). Analyses of bone mineral density, calcium-phosphorous and bone metabolism and lithogenic risk factors in fasting urine samples and 24-h urine samples were performed. Statistical analysis was carried out with SPSS 17.0. A p â‰¤ 0.05 was considered statistically significant. RESULTS: Patients in Group 2 presented greater loss of bone mineral density and more elevated alkaline phosphatase, iPTH, phosphorous and ß-crosslaps levels, as compared to patients in Group 1. However, Group 1 presented greater urine calcium, oxalate and uric acid and a higher proportion of hypocitraturia, hypercalciuria and hyperoxaluria, as compared to Group 2. Multivariate analysis revealed that advanced age and ß-crosslaps levels are risk factors for bone mineral density loss, while low urinary calcium excretion was protective against bone demineralization. CONCLUSION: Patients with osteopenia/osteoporosis without lithiasis present some urinary biochemical alterations. This would explain the lack of lithogenic activity, although low calcium excretion in 24-h urine samples is a protective factor against the loss of bone mineral density.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1502
[Js] Journal subset:IM
[St] Status:In-Data-Review
[do] DOI:10.1007/s11255-015-0918-z

  10 / 5813 MEDLINE  
              first record previous record
select
to print
Photocopy
Full text

[PMID]: 25415699
[Au] Autor:Glazer DI; Maturen KE; Cohan RH; Davenport MS; Ellis JH; Knoepp US; Weadock WJ; Platt JF
[Ad] Address:1 Department of Radiology, University of Michigan Health System, UH B1 D502, 1500 E Medical Center Dr, Ann Arbor, MI 48109.
[Ti] Title:Assessment of 1 mSv urinary tract stone CT with model-based iterative reconstruction.
[So] Source:AJR Am J Roentgenol;203(6):1230-5, 2014 Dec.
[Is] ISSN:1546-3141
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:OBJECTIVE: The purpose of this study was to evaluate stone detection, assessment of secondary signs of stone disease, and diagnostic confidence utilizing submillisievert CT with model-based iterative reconstruction (MBIR) in a North American population with diverse body habitus. MATERIALS AND METHODS: Fifty-two adults underwent stone CT using a split-dose protocol; weight-based projected volume CT dose index (CTDIvol) and dose-length product (DLP) were divided into two separate acquisitions at 80% and 20% dose levels. Images were reconstructed with MBIR. Five blinded readers counted stones in three size categories and rated "overall diagnostic confidence" and "detectability of secondary signs of stone disease" on a 0-4 scale at both dose levels. Effective dose (ED) in mSv was calculated as DLP multiplied by conversion coefficient, k, equal to 0.017. RESULTS: Mean ED (80%, 3.90±1.44 mSv; vs 20%, 0.97±0.34 mSv [p<0.001]) and number of stones detected (80%, 193.6±25.0; vs 20%, 154.4±15.4 [p=0.03]) were higher in scans at 80% dose level. Intrareader correlation between scans at 80% and 20% dose levels was excellent (0.83-0.97). With 80% scans as reference standard, mean sensitivity and specificity at 20% varied with stone size (<3 mm, 74% and 77%; ≥3 mm, 92% and 82%). The 20% scans scored lower than 80% scans in diagnostic confidence (2.46±0.50; vs 3.21±0.36 [p<0.005]) and detectability of secondary signs (2.41±0.39; vs 3.19±0.29 [p<0.005]). CONCLUSION: Aggressively dose-reduced (~1 mSv) MBIR scans detected most urinary tract stones of 3 mm or larger but underperformed the low-dose reference standard (3-4 mSv) scans in small (<3 mm) stone detection and diagnostic confidence.
[Mh] MeSH terms primary: Models, Biological
Radiation Dosage
Radiation Protection/methods
Radiographic Image Enhancement/methods
Radiographic Image Interpretation, Computer-Assisted/methods
Tomography, X-Ray Computed/methods
Urolithiasis/radiography
[Mh] MeSH terms secundary: Adult
Aged
Aged, 80 and over
Algorithms
Computer Simulation
Female
Humans
Male
Middle Aged
Reproducibility of Results
Sensitivity and Specificity
Young Adult
[Pt] Publication type:CLINICAL TRIAL; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Entry month:1502
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:141122
[St] Status:MEDLINE
[do] DOI:10.2214/AJR.13.12271


page 1 of 582 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information